Why the study?
Disrupt CAD IV showed low 30-day MACE and high procedural success following IVL in severe coronary artery calcification, but long-term outcomes had not been reported.
Does intravascular lithotripsy improve 1-year outcomes in patients with severe coronary artery calcification prior to stent placement?
Does intravascular lithotripsy improve 1-year outcomes in patients with severe coronary artery calcification prior to stent placement?
This analysis evaluates the 1-year outcomes of intravascular lithotripsy for severe coronary artery calcification in the Japanese Disrupt CAD IV study.
Answers are grounded in this paper and cite their sources.
1-year Japanese cohort data on IVL for severe CAC; leaves open comparative efficacy versus alternatives.
Background: Intravascular lithotripsy (IVL) delivers acoustic pressure waves to modify calcium, enhance vessel compliance, and optimize stent deployment. The Disrupt CAD IV study enrolled patients with severe coronary artery calcification and demonstrated low 30-day major adverse cardiovascular events (MACE) and high procedural success following IVL with no final serious angiographic complications. To date, long-term outcomes have not been reported. This analysis evaluates 1-year outcomes of Disrupt CAD IV.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2022) studied Severe coronary artery calcification (n=64). Intravascular lithotripsy (IVL) was evaluated on Major adverse cardiovascular events (MACE) at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: